These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1970345)

  • 21. Analysis of drugs from biological fluids using disposable solid phase columns.
    Doyle E; Pearce JC; Picot VS; Lee RM
    J Chromatogr; 1987 Dec; 411():325-33. PubMed ID: 2895114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.
    Desager JP; Harvengt C
    J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nizatidine, and H2-receptor antagonist: disposition and safety in the elderly.
    Callaghan JT; Rubin A; Knadler MP; Bergstrom RF
    J Clin Pharmacol; 1987 Aug; 27(8):618-24. PubMed ID: 2888796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrophotometric determination of nizatidine in pharmaceutical preparations.
    Minic D; Petkovic J; Koricanac Z; Jovanovic T
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1355-8. PubMed ID: 8818056
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of a new calcium antagonist, sesamodil fumarate (SD-3211), and its metabolite in plasma by liquid chromatography with electrochemical detection.
    Morishima K; Tahara R; Horiuchi M
    J Chromatogr; 1990 May; 527(2):381-8. PubMed ID: 2387885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
    Levendoglu H; Mehta B; Wait C; Reddy G; Hatcher C
    Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of nizatidine in total nutrient admixtures.
    Hatton J; Holstad SG; Rosenbloom AD; Westrich T; Hirsch J
    Am J Hosp Pharm; 1991 Jul; 48(7):1507-10. PubMed ID: 1679293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M; Holdcroft C
    Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatographic assay of nesosteine in human plasma and urine.
    Girometta MA; Loschi L; Ventura P
    J Chromatogr; 1989 Jan; 487(1):117-24. PubMed ID: 2715254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of nizatidine in commonly used intravenous fluids and containers.
    Raineri DL; Cwik MJ; Rodvold KA; Deyo KL; Scaros LP; Fischer JH
    Am J Hosp Pharm; 1988 Jul; 45(7):1523-9. PubMed ID: 3137816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of nizatidine into human breast milk after single and multiple doses.
    Obermeyer BD; Bergstrom RF; Callaghan JT; Knadler MP; Golichowski A; Rubin A
    Clin Pharmacol Ther; 1990 Jun; 47(6):724-30. PubMed ID: 1972674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry.
    Zhong L; Eisenhandler R; Yeh KC
    J Mass Spectrom; 2001 Jul; 36(7):736-41. PubMed ID: 11473396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
    Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
    Electrophoresis; 2001 Aug; 22(13):2758-62. PubMed ID: 11545404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Efficient Ion-Pair Liquid Chromatographic Method for the Determination of Some H2 Receptor Antagonists.
    Elshaboury SR; Mohamed NA; Ahmed S; Farrag S
    J Chromatogr Sci; 2016 Mar; 54(3):419-28. PubMed ID: 26538490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new rapid HPLC assay for the simultaneous determination of two histamine H2-receptor antagonists, cimetidine and ranitidine, in human plasma.
    Tracqui A; Kintz P; Mangin P; Lugnier AA; Chaumont AJ
    J Toxicol Clin Exp; 1988; 8(6):387-94. PubMed ID: 2856577
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of nizatidine in extemporaneous oral liquid preparations.
    Lantz MD; Wozniak TJ
    Am J Hosp Pharm; 1990 Dec; 47(12):2716-9. PubMed ID: 1980576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrophotometric and titrimetric determination of nizatidine in capsules.
    El-Yazbi FA; Gazy AA; Mahgoub H; El-Sayed MA; Youssef RM
    J Pharm Biomed Anal; 2003 Apr; 31(5):1027-34. PubMed ID: 12684116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual compatibility of intravenous famotidine with selected drugs.
    Fong PA; Ward J
    Am J Hosp Pharm; 1989 Jan; 46(1):125-6. PubMed ID: 2565686
    [No Abstract]   [Full Text] [Related]  

  • 40. High-performance liquid chromatographic determination of oxmetidine in human plasma: comparison of liquid-liquid and liquid-solid extraction techniques.
    McDowall RD; Murkitt GS; Walford JA
    J Chromatogr; 1984 Dec; 317():475-81. PubMed ID: 6152271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.